NCT03917641

Brief Summary

The post operative routine after Oculoplastic Surgery includes usage of cold compressions for symptomatic relief and decreasing of the edema and local hematomas in the first few days after the surgery. Khat (Catha edulis) is a plant that is used mainly for chewing and has a known stimulating effect, some patients report major improvement after including these leaves in the compressions they use after surgery. Khat contains the chemical ingredients Cathine and Cathinone, which are amphetamine-like alkaloids and probably the main contributors for its active effects. Our main goal is to use compressions that include the Khat leaves and check their effect on reducing the edema and hematomas after oculoplastic surgery.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 1, 2019

Completed
16 days until next milestone

First Posted

Study publicly available on registry

April 17, 2019

Completed
3 months until next milestone

Study Start

First participant enrolled

July 1, 2019

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2020

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2021

Completed
Last Updated

April 17, 2019

Status Verified

April 1, 2019

Enrollment Period

1 year

First QC Date

April 1, 2019

Last Update Submit

April 13, 2019

Conditions

Keywords

Oculoplastic SurgeryKhat leavesPost operative careEdemaHematoma

Outcome Measures

Primary Outcomes (2)

  • Edema

    Improvement in edema in the Khat compression in comparison to standard compression by clinical evaluation.

    7 days post op

  • Hematoma

    Improvement in hematomas in the Khat compression in comparison to standard by compression by clinical evaluation.

    7 days post op

Study Arms (1)

Patients after Oculoplastic surgery

EXPERIMENTAL

Each participant will use one compression with Khat leaves and another standard compression and will decide on which eye to use which compression. The compressions will be used for 10 minutes per every waking hour in the first 2 days post-op. The patient will take pictures of both his eyes in days 1,3 and 7 post operative days.

Biological: Khat leaves

Interventions

Khat leavesBIOLOGICAL

One of the two compressions (one per each eye) the patient will use will contain the Khat leaves.

Patients after Oculoplastic surgery

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients who underwent blepharoplasty and/or ptosis repair

You may not qualify if:

  • Patients who were operated on one eye only
  • Patients who underwent a different surgery in each eye

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sheba_Medical_Center

Ramat Gan, 52621, Israel

Location

Related Publications (1)

  • Malhotra R, Ziahosseini K, Poitelea C, Litwin A, Sagili S. Effect of Manuka Honey on Eyelid Wound Healing: A Randomized Controlled Trial. Ophthalmic Plast Reconstr Surg. 2017 Jul/Aug;33(4):268-272. doi: 10.1097/IOP.0000000000000743.

    PMID: 27429228BACKGROUND

MeSH Terms

Conditions

HematomaSurgical WoundEdema

Condition Hierarchy (Ancestors)

HemorrhagePathologic ProcessesPathological Conditions, Signs and SymptomsWounds and InjuriesSigns and Symptoms

Central Study Contacts

Guy J Ben Simon, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Each participant is his own control
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 1, 2019

First Posted

April 17, 2019

Study Start

July 1, 2019

Primary Completion

July 1, 2020

Study Completion

July 1, 2021

Last Updated

April 17, 2019

Record last verified: 2019-04

Locations